California Cancer Associates for Research and Excellence

Recent papers from California Cancer Associates for Research and Excellence

1. From neuroscience to oncology: Multi-agent AI replicating neural reasoning architecture for evidence-based colon cancer clinical decisions.Journal of Clinical Oncology · 2026
2. Interstitial lung disease risk and outcomes across HER2-targeted therapies commonly used in breast cancer: Analysis of real-world FAERS data.Journal of Clinical Oncology · 2026
3. Integrating RM Y-STRs into South African sexual offence casework: a narrative, problem-oriented reviewAustralian Journal of Forensic Sciences · 2026
4. Survey of work-from-home experiences among medical physicists in Southern California during and after the COVID-19 pandemic.2026
5. Sociodemographic disparities in the place of death in patients with colorectal cancer: Analysis of real-world CDC WONDER data.Journal of Clinical Oncology · 2026
6. Immune checkpoint inhibitor (ICI) associated corneal allograft rejectionCancer Treatment and Research Communications · 2026
7. Automated contouring, treatment planning, and quality assurance for total marrow lymphoid irradiationFrontiers in Oncology · 2025
8. Automated contouring, treatment planning, and quality assurance for total marrow lymphoid irradiationFrontiers in Oncology · 2025
9. Validation of the FACIT-Fatigue Scale in Patients With Locally Advanced or Metastatic Breast CancerThe Oncologist · 2025
10. Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationSignal Transduction and Targeted Therapy · 2025
11. A phase 1 study of fianlimab (anti–LAG-3) in combination with cemiplimab (anti–PD-1) in patients with advanced HNSCC.Journal of Clinical Oncology · 2024
12. Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate pepinemab in combination with pembrolizumab for first-line treatment of patients with recurrent or metastatic head and neck cancer.Journal of Clinical Oncology · 2024
13. Fractionated external-beam radiation therapy in elderly patients.Journal of Clinical Oncology · 2024
14. Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal CancerClinical Colorectal Cancer · 2024
15. 372 TABLET: food effect study of niraparib tablets in patients with advanced solid tumours2024
16. A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid TumorsClinical Therapeutics · 2024
17. Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final resultsBlood Advances · 2024
18. Characteristics and Challenges of Providing Acupuncture and Chinese Herbal Medicine in Oncology Treatment: Report of Survey Data and Experience of Five Unique Clinical SettingsIntegrative Cancer Therapies · 2024
19. BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumorsCancer Gene Therapy · 2023
20. Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing MiceCells · 2023